Table 1 Characteristics of 27 included studies in the systematic review
Reference | Study year(s) | Location | Design | Center | Number of patients | Outcome | Main type of infection | Severity index scale and significance difference | |
|---|---|---|---|---|---|---|---|---|---|
Number | Type | ||||||||
Kim et al. [21]a | 1998-2001 | Korea | R | 1 | U | 127 | M | MRSA bacteremia | McCabe’s classification, Jackson: NS |
Kang et al. [12]a | 1998-2002 | Korea | R | 2 | U, G | 286 | M | Antibiotic-resistant Gram-negative Bacilli BSI | APACHE II: NS |
Micek et al. [33]a | 1997-2002 | USA | R | 1 | U | 305 | M | Pseudomonas aeruginosa BSI | SAPS II: NC |
Luna et al. [34] | 1999-2003 | Argentina | P | 6 | NM | 76 | M | Pneumonia (VAP) | APACHE II: NS |
Kim et al. [8] | 1998-2001 | South Korea | R | 1 | U | 238 | M | SAB | McCabe’s classification, Jackson: NS |
Scarsi et al. [22]a | 2001-2003 | USA | R | 1 | U | 884 | M | Gram-negative BSI | Charlson index: NS |
Marschall et al. [36]a | 2006-2007 | USA | P | 1 | T | 250 | M LOS | Gram-negative bacteremia | Charlson index, McCabe’s classification: NS |
Shorr et al. [37]a | 2002-2004 | USA | R | 1 | U | 291 | M LOS C | MRSA infection | NM |
RodrÃguez-Baño et al. [38]a | 2003 | Spain | P | 59 | U, G | 209 | M | Sepsis | Charlson index: NC |
Ammerlaan et al. [39]a | 2007 | West European countries | R | 60 | T, G | 334 | M | SAB | Modified Charlson index: NS |
Erbay et al. [19]a | 2005-2008 | Turkey | R | 1 | U | 103 | M | Acinetobacter baumannii bacteremia | APACHE II: NC |
Kumar et al. [40]a | 1996-2005 | Canada, USA, Saudi Arabia | R | 22 | U | 5,715 | M | Septic shock | APACHE II: NC |
Tseng et al. [41]a | 2005-2007 | Taiwan | R | 1 | T | 163 | M | Pneumonia | Charlson index: NC |
Micek et al. [42]a | 2002-2007 | USA | R | 1 | U | 760 | M | Gram-negative sepsis | APACHE II, Charlson index: NS |
Paul et al. [43]a | 1999-2007 | Israel | R | 1 | NM | 510 | M | MRSA bacteremia | NM |
Joung et al. [44]a | 2000-2006 | Korea | R | 1 | U | 116 | M | Pneumonia (HAP) Acinetobacter baumannii | APACHE II: NS |
Shorr et al. [45] | 2002-2007 | USA | R | 1 | U | 760 | LOS | Gram-negative sepsis | APACHE II, Charlson index: NS |
Suppli et al. [46]a | 2002-2005 | Denmark | R | 1 | T | 196 | M | Enterococcal BSI | Charlson index: NS, except score 0 (P = 0.04) |
Reisfeld et al. [47]a | 2005-2007 | Israel | R | 1 | G | 378 | M | Gram-negative bacteremia | NM |
Wilke et al. [48]a | 2007 | Germany | R | 5 | T | 221 | M LOS C | Pneumonia (VAP, HAP) | NM |
Lye et al. [50]a | 2007-2009 | Singapore | R | 2 | G | 675 | M | Gram-negative bacteremia | APACHE II <0.001; Charlson index: NS |
Tseng et al. [51] | 2007-2008 | Taiwan | R | 1 | U | 163 | M | Pneumonia (VAP) | APACHE II, Charlson index, SOFA: NC |
Chen et al. [52] | 2006-2011 | China | R | 1 | T | 118 | M | SAB | APACHE II: NC |
Labelle et al. [54]a | 2002-2007 | USA | R | 1 | T | 436 | M | Septic shock | APACHE II, Charlson index: NC |
Chen et al. [55] | 2008-2009 | Taiwan | P | 1 | U | 937 | M, LOS | BSI | MEDS, Charlson index: NC |
Frakking et al. [56]a | 2008-2010 | The Netherlands | R | 8 | U | 232 | M | ESBL bacteremia | Pitt bacteremia score: NS |
Tumbarello et al. [57]a | 2008-2010 | Italy | R | 1 | U | 110 | M | Pseudomonas aeruginosa pneumonia | SAPS II, SOFA: NS |